Salarius Pharmaceuticals
SLRX
SLRX
16 hedge funds and large institutions have $18.6M invested in Salarius Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $17K
Holders
16
Holding in Top 10
–
Calls
–
Puts
$17K
Top Buyers
| 1 | +$2.34M | |
| 2 | +$260K | |
| 3 | +$246K | |
| 4 |
Renaissance Technologies
New York
|
+$183K |
Top Sellers
| 1 | -$614K | |
| 2 | -$386K | |
| 3 | -$296K | |
| 4 |
Millennium Management
New York
|
-$249K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$154K |